Results 191 to 200 of about 254,141 (317)

Retinoblastoma Protein Is Functionally Distinct from Its Homologues in Affecting Glucocorticoid Receptor-mediated Transcription and Apoptosis [PDF]

, 2001
Paramjeet Singh, Siew Wee Chan, Wanjin Hong   +2 more
openalex   +1 more source

The glucocorticoid receptor

Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1991
Muller, Marc, Renkawitz, R.
openaire   +3 more sources

Associations Between Changes in Pain Sensitization and Disease Activity Following Disease‐Modifying Antirheumatic Drug Therapy in Established Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Abnormalities in pain regulatory mechanisms are common in patients with rheumatoid arthritis (RA). We investigated whether pain sensitization changes after treatment with a disease‐modifying antirheumatic drug (DMARD) and explored associations between changes in pain sensitization and disease activity.
Burcu Aydemir, Andrew C. Heisler, Lutfiyya N. Muhammad, Jing Song, Alyssa Wohlfahrt, Daniel J. Clauw, Wendy Marder, Marcy B. Bolster, Clifton O. Bingham, Tuhina Neogi, Yvonne C. Lee   +10 more
wiley   +1 more source

Resveratrol restores glucocorticoid receptor and HDAC2 to overcome corticosteroid resistance in cigarette smoke-induced emphysema mice. [PDF]

J Thorac Dis
Huo Z, Chen X, Zheng G, Wei X, Huang Y, Zou J, Ou S, Xu C, Yang Y, Chen S, Bai J.   +10 more
europepmc   +1 more source

Effect of Glucocorticoid on Piglet Jejunal Mucosa during Acute Viral Enteritis [PDF]

, 1988
J. Marc Rhoads, John Macleod, J. R. Hamilton   +2 more
openalex   +1 more source

Efficacy and Safety of ABBV‐154 for the Treatment of Active Rheumatoid Arthritis: A Phase 2b, Randomized, Placebo‐Controlled Trial

Arthritis &Rheumatology, EarlyView.
Objective Despite the availability of biologic and targeted synthetic disease‐modifying antirheumatic drugs (b/tsDMARDs) to treat rheumatoid arthritis (RA), many patients do not experience optimized disease control. Glucocorticoids are effective but have safety risks.
Frank Buttgereit, Atul Singhal, Alan Kivitz, Edit Drescher, Yoshinori Taniguchi, Rosalía Martínez Pérez, Jaclyn Anderson, Ronilda D'Cunha, Weihan Zhao, Nicholas DeVogel, Julie Parmentier, Romy Christmann, Dilek Arikan, Howard Amital   +13 more
wiley   +1 more source

What is the need for adrenalectomy in patients with congenital adrenal hyperplasia in the era of CRF1/ACTH inhibitors? [PDF]

Front Endocrinol (Lausanne)
Fedorova O, Falhammar H.
europepmc   +1 more source

Inhibition of glucocorticoid‐induced epidermal and dermal atrophy with KH 1060 – a potent 20‐epi analogue of 1,25‐dihydroxyvitamin D₃ [PDF]

, 1994
Robert Gniadecki, Monika Gniadecka, Jørgen Serup   +2 more
openalex   +1 more source

Glucocorticoid antagonists

FEBS Letters, 1987
Agarwal, M.K., Hainque, B., Moustaid, N., Lazer, G.   +3 more
openaire   +2 more sources

Expert Perspective: Diagnosis and Treatment of Castleman Disease

Arthritis &Rheumatology, EarlyView.
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen, Lu Zhang, David C. Fajgenbaum   +2 more
wiley   +1 more source